Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis-Related Prognostic Gene LAMP2 Is a Potential Biomarker Differential Expressed in Castration Resistant Prostate Cancer. | Dis Markers | 2023 | 36741911 | PubTator, text mining | PubMed |
| NBS1 binds directly to TOPBP1 via disparate interactions between the NBS1 BRCT1 domain and the TOPBP1 BRCT1 and BRCT2 domains. | DNA Repair (Amst) | 2023 | 36738687 | PubTator, text mining | PubMed |
| The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma. | Cancer Med | 2023 | 36708047 | PubTator, text mining | PubMed |
| Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications. | Mitochondrion | 2023 | 36690315 | PubTator, text mining | PubMed |
| EEPD1 promotes repair of oxidatively-stressed replication forks. | NAR Cancer | 2023 | 36683914 | PubTator, text mining | PubMed |
| Design and Characterization of Mutated Variants of the Oncotoxic Parvoviral Protein NS1. | Viruses | 2023 | 36680249 | PubTator, text mining | PubMed |
| The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy. | Pharmaceuticals (Basel) | 2023 | 36678591 | PubTator, text mining | PubMed |
| Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. | Int J Mol Sci | 2023 | 36674619 | PubTator, text mining | PubMed |
| DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36672401 | PubTator, text mining | PubMed |
| Human DNA ligases I and III have stand-alone end-joining capability, but differ in ligation efficiency and specificity. | Nucleic Acids Res | 2023 | 36625284 | PubTator, text mining | PubMed |
| Nuclear factor Nrf2 promotes glycosidase OGG1 expression by activating the AKT pathway to enhance leukemia cell resistance to cytarabine. | J Biol Chem | 2023 | 36528059 | PubTator, text mining | PubMed |
| Quantitative Analysis of Nuclear Poly(ADP-Ribose) Dynamics in Response to Laser-Induced DNA Damage. | Methods Mol Biol | 2023 | 36515828 | PubTator, text mining | PubMed |
| Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36406320 | PubTator, text mining | PubMed |
| Leveraging the replication stress response to optimize cancer therapy. | Nat Rev Cancer | 2023 | 36323800 | PubTator, text mining | PubMed |
| Identification of natural marine compounds as potential inhibitors of CDK2 using molecular docking and molecular dynamics simulation approach. | J Biomol Struct Dyn | 2023 | 36300512 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Triple negative breast cancer: approved treatment options and their mechanisms of action. | J Cancer Res Clin Oncol | 2023 | 35976445 | PubTator, text mining | PubMed |
| PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response. | Cell Biol Toxicol | 2023 | 35778544 | PubTator, text mining | PubMed |
| Is autophagy induction by PARP inhibitors a target for therapeutic benefit? | Oncol Res | 2022 | 37304006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=11